comparemela.com

Latest Breaking News On - Biosimilar - Page 8 : comparemela.com

Decision-Making Process Surrounding Biosimilar Implementation

Experts compare approaches to prescribing biosimilars over reference drugs.

Aliceb gottliebBincy abrahamRyan haumschildJamiet broganVibeke strandEvidence based medicinePsoriatic arthritisPrior authorization

Switchback from Biosimilar to Biologic Rare Among Veteran Patients

Very few patients switch off a biosimilar due to adverse effects, according to a new study.

Kellym bryanVeterans affairsInternational conference on pharmacoepidemiologyMedication centerVeterans affairs va centerInternational conferenceTherapeutic risk managementAnnual meeting

Trastuzumab Biosimilar Use Significantly Increasing in the US

Analysis shows the rate of use with the originator biologic has decreased from 90% in 2016, to 19% in 2021.

United statesHerceptin biosimilarMai xiaodanTrastuzumab biosimilarBiologics biosimilars collective intelligence consortiumHarvard pilgrim health care instituteDrug administrationInternational conference on pharmacoepidemiologyHarvard medical schoolInternational conferenceTherapeutic risk managementAnnual meetingBiosimilars collective intelligence consortiumThird herceptinPublished januaryBreast cancer

Switching with Adalimumab Biosimilar Maintains Benefit for Plaque Psoriasis

Trial data support multiple switching between biosimilar and reference product over a 48-week course for the treatment of psoriasis.

Baylor scott whiteAlan menterDrug administrationBaylor scottPsoriasis area severity indexGlobal physicians assessmentPlaque psoriasisPhase 3

Infliximab Biosimilars Not Linked to Worsened Infection Risk

An analysis of national Canadian data suggest patients receiving either originator or biosimilar infliximab are at a similar risk of the common adverse event.

Marinag birckLinkedin marinag birckCanadian national prescription drug utilization information systemNational ambulatory care reporting systemInternational conference on pharmacoepidemiologyInternational conferenceTherapeutic risk managementAnnual meetingResearch instituteMcgill university health centreHospital discharge abstract databaseNational ambulatory care reporting

vimarsana © 2020. All Rights Reserved.